Assessing the Effect of the Silver Dressing on Surgical Site Infections in Adult Patients Post Cardiac Surgery: a Single Center Randomized Control Trial
Launched by KING FAISAL SPECIALIST HOSPITAL & RESEARCH CENTER · May 29, 2025
Trial Information
Current as of July 27, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Background The prevalence of surgical site infections in cardiac surgery is about 10%. About 3% of patients who develop an SSI will die as a result. Multiple studies confirm that SSIs are complications with significant sequelae, such as longer hospitalization, increased health costs, increased morbidity, and mortality. Hence, the prevention and management of wound infections in median sternotomy incisions after adult cardiac surgery are crucial for optimizing patient outcomes, 5 Aim To assess the effect of the silver dressing on SSI rates in adult patients post-cardiac surgery.
Methodology...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients 18 years of age and older are scheduled for cardiac surgery requiring a sternotomy incision.
- • Exclusion criteria Presence of a concurrent infection and any systemic antibiotic other than those used for perioperative prophylaxis.
- • Patients who died without an infection within thirty days following surgery. Patients who had undergone another procedure through the same incision(s) within a year after enrollment in this study.
- • Patients who are a redo- such as needing debridement or an infection. Patients who have an open chest Patients on ECHMO Patients excessively bleeding Patients who require the surgery as an emergency Patients with a known allergy to silver dressings
- • -
About King Faisal Specialist Hospital & Research Center
King Faisal Specialist Hospital & Research Center (KFSH&RC) is a leading medical institution in Saudi Arabia, dedicated to providing advanced healthcare services, conducting pioneering research, and training healthcare professionals. Founded in 1975, KFSH&RC specializes in comprehensive patient care across various disciplines, including oncology, organ transplantation, and genetics. The center is recognized for its commitment to clinical excellence and innovation, actively participating in clinical trials to enhance treatment options and improve patient outcomes. With state-of-the-art facilities and a multidisciplinary team of experts, KFSH&RC plays a pivotal role in advancing medical knowledge and improving healthcare standards in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jeddah, , Saudi Arabia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported